DIGITAL medication platform provider, MedAdvisor (MDR), is set to acquire GuildLink in a deal worth $9.1 million.
MDR announced it has entered into a binding agreement to purchase 100% of the shares in GuildLink from Guild Group Holdings Limited offering in consideration of the issue of 57,118,490 ordinary shares in the Australian Securities Exchange (ASX) listed company.
As part of the deal, Pharmacy Guild of Australia Health Economics and Policy Chair, Anthony Tassone, has been appointed to the MDR Board as a nominee of the Guild Group, effective 27 Jul - subject to the successful completion of the deal.
MDR said the acquisition will extend the company's market to include more than 90% of Australia's community pharmacies, providing a consolidated platform for all government programs, and delivering more diversified revenue streams.
Guild National President, Trent Twomey, said the deal would provide improved services for the sector and patients.
"This transaction provides certainty for our ability to continue to deliver health service initiatives aimed at improving the health and wellness of Australians while providing an enhanced medications management technology platform that meets the ongoing needs of community pharmacy," he said.
"It's a positive step forward for the pharmacy community and for all Australians."
MDR Chair, Linda Jenkinson, said the company was focused on improving pharmacists' workflow, to enable them to provide better care to their patients.
"As pharmacies widen their scope of practice, and governments seek a more consistent approach to engaging with the pharmacy sector, our strong belief is that a best-of-breed platform is the best way to enable the industry to achieve these objectives," she said.
"MDR's acquisition of GuildLink deepens our relationship with the Guild and the many pharmacies supported by GuildLink.
"There is compelling strategic rationale for the acquisition as it ensures Australian pharmacists have access to the world's best technology platform that integrates patient bookings, clinical services, vaccinations and medication management, while also having the additional benefit of being supported by the Guild to ensure they are remunerated appropriately for delivering these services."
The above article was sent to subscribers in Pharmacy Daily's issue from 25 Jul 22
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 25 Jul 22